| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 16 May 2026 | 12 May 2026 |
| Neogen Chemicals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 ,inter alia, to consider and approve 1) Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended on March 31, 2026; 2) Recommendation of a final dividend, if any, on the equity shares of the Company, for the financial year ended March 31, 2026, subject to declaration and approval of the same by the shareholders at the ensuing 37th Annual General Meeting. Approval of Audited Financial Results (Standalone and Consolidated) of the Company Company along with the Audit Reports for the Quarter and Financial Year ended March 31, 2026 and Asset cover certificate, recommendation of final dividend, Amendments to the Code for prevention of insider trading in the securities of Neogen Chemicals Limited,4. Details of Outstanding Qualified Borrowings and Incremental Qualified Borrowings for F.Y. 2025-26 and Other regulation 30 announcement. (As Per BSE Announcement Dated on: 16/05/2026) | ||
| Board Meeting | 7 Mar 2026 | 4 Mar 2026 |
| Preferential Issue of shares & Inter alia, to consider and approve the proposal for raising of funds by way of issue of equity shares on preferential basis and other connected matters. Outcome of board meeting approving issue of 1000000 equity shares on preferential issue basis and approving Notice of EGM and related timelines. (As Per BSE Announcement Dated on:07.03.2026) | ||
| Board Meeting | 11 Feb 2026 | 6 Feb 2026 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Intimation of Board Meeting to be held on February 11 2026. Outcome of Board meeting approving unaudited financial results of the company for the quarter and nine months ended 31-12-2025. (As per BSE announcement dated on : 11.02.2026) | ||
| Board Meeting | 8 Nov 2025 | 5 Nov 2025 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 inter alia to consider and approve Intimation of Board meeting to be held on November 8 2025 Outcome of Board meeting (As Per BSE Announcement Dated on 08.11.2025) | ||
| Board Meeting | 2 Aug 2025 | 30 Jul 2025 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2025 inter alia to consider and approve Un-audited standalone and consolidated financial results of the Company for the quarter ended on June 30 2025. Outcome of Board Meeting held on August 2, 2025. (As Per BSE Announcement Dated on: 02/08/2025) | ||
| Board Meeting | 12 Jul 2025 | 9 Jul 2025 |
| Inter alia, to consider, evaluate and approve the proposal for raising of funds by way of issue of non-convertible debentures through permissible mode(s), subject to such regulatory and other approvals as may be required in this regard. Approval of Board for Fund raising by way of issue of non- convertible debentures and noting of Notice received from BSE. (As Per BSE Announcement dated on 12.07.2025) | ||
| Board Meeting | 3 Jun 2025 | 3 Jun 2025 |
| 1) Continuation of Directorship of Prof. Ranjan Kumar Malik 2) Calendar of Events for Postal Ballot 3) Notice received from NSE. | ||
Solid LiPF6 salt is a critical raw material for making electrolyte used in lithium-ion batteries, placing the JV directly in a high-demand supply chain.
The company added that the securities will be backed through hypothecation and mortgage, creating a subservient charge on assets.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
